Crizotinib in ALK-positive lung cancer

Lancet Oncol. 2012 Oct;13(10):962-3. doi: 10.1016/S1470-2045(12)70375-3. Epub 2012 Sep 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Crizotinib
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Pyridines / therapeutic use*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*

Substances

  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Crizotinib
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases